Muricholic Acids Inhibit Clostridium difficile Spore Germination and Growth
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Infections caused by Clostridium difficile have increased steadily over the past several years. While studies on C. difficile virulence and physiology have been hindered, in the past, by lack of genetic approaches and suitable animal models, newly developed technologies and animal models allow these processes to be studied in detail. One such advance is the generation of a mouse-model of C. difficile infection. The development of this system is a major step forward in analyzing the genetic requirements for colonization and infection. While important, it is equally as important in understanding what differences exist between mice and humans. One of these differences is the natural bile acid composition. Bile acid-mediated spore germination is an important step in C. difficile colonization. Mice produce several different bile acids that are not found in humans. These muricholic acids have the potential to impact C. difficile spore germination. Here we find that the three muricholic acids (α-muricholic acid, β-muricholic acid and ω-muricholic acid) inhibit C. difficile spore germination and can impact the growth of vegetative cells. These results highlight an important difference between humans and mice and may have an impact on C. difficile virulence in the mouse-model of C. difficile infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829 · cited 4×
“In humans, bile acids are synthesized in the liver as either cholic acid (3a, 7a, 12a-trihydroxy-5b-cholanic acid) or chenodeoxycholic acid [3a, 7a,-dihydroxy-5b-cholanic acid (CDCA)] [27].”
BackgroundInfluentialBile Salts and Glycine as Cogerminants for Clostridium difficile Spores
Sorg, J. A., & Sonenshein, A. L. (2008) · Journal of Bacteriology · doi:10.1128/jb.01765-07 · Cited by 711 · cited 5×
“difficile spores on rich medium occurs after exposure to cholic acid derivatives [31,32].”
BackgroundResultInfluentialSelf-citationBuffie, C. G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., & Pamer, E. G. (2012) · Infection and Immunity · doi:10.1128/iai.05496-11 · Cited by 596 · cited 1×
“Several mouse models of infection have been developed [5,13,14,15,16,17].”
BackgroundLawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002995 · Cited by 540 · cited 3×
“difficile strains have been shown to stably colonize mice and enter a ‘contagious’ state, where disease is limited but spore shedding is maintained, while other strains are cleared by the host [13,17].”
BackgroundA mouse model of clostridium difficile-associated disease
Chen, X., Katchar, K., Goldsmith, J. D., Nanthakumar, N., Cheknis, A., Gerding, D. N., & Kelly, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.002 · Cited by 510 · cited 4×
“Further, antibiotic-treated mice can relapse after a course of antibiotic treatment, to cure the primary infection, and will express some resistance to reinfection when allowed to fully recover from disease [14].”
BackgroundInfluentialLawley, T. D., Clare, S., Walker, A. W., Goulding, D., Stabler, R. A., Croucher, N., Mastroeni, P., Scott, P., Raisen, C., Mottram, L., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00558-09 · Cited by 349 · cited 6×
“Several mouse models of infection have been developed [5,13,14,15,16,17].”
BackgroundMethodInfluentialSorg, J. A., & Sonenshein, A. L. (2010) · Journal of Bacteriology · doi:10.1128/jb.00610-10 · Cited by 332 · cited 10×
“Subsequent work has shown that all cholic acid derivatives and some amino acids, commonly glycine, can stimulate the initiation of spore germination while CDCAderivatives are competitive inhibitors of cholic acid-mediated germination [31,33,34,35,36].”
BackgroundMethodResultInfluentialSelf-citationReeves, A. E., Koenigsknecht, M. J., Bergin, I. L., & Young, V. B. (2012) · Infection and Immunity · doi:10.1128/iai.00647-12 · Cited by 292 · cited 1×
“Gnotobiotic neonatal piglets, rats, and germ-free mice have all been used to varying degrees of success [3,4,5,6].”
Human cecal bile acids: concentration and spectrum
Hamilton, J. P., Xie, G., Raufman, J.-P., Hogan, S., Griffin, T. L., Packard, C. A., Chatfield, D. A., Hagey, L. R., Steinbach, J. H., & Hofmann, A. F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00027.2007 · Cited by 263 · cited 1×
“difficile growth for the individual bile acids tested (Table 2); variations in pH may affect the toxicity of each bile acid [53].”
BackgroundChenodeoxycholate Is an Inhibitor of Clostridium difficile Spore Germination
Sorg, J. A., & Sonenshein, A. L. (2009) · Journal of Bacteriology · doi:10.1128/jb.01260-08 · Cited by 199
Self-citationMiyata, M., Takamatsu, Y., Kuribayashi, H., & Yamazoe, Y. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160093 · Cited by 72 · cited 2×
“Specifically, the authors identified that small intestine, lumenal concentrations of taurocholic acid, tauro-b-muricholic acid and taurochenodeoxycholic acid were more abundant in antibiotictreated C57/BL6 mice than in vehicle-only controls [54]; the authors did not measure the levels of AMA.”
Background
Cited by
Consequences of bile salt biotransformations by intestinal bacteria
Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D.-J., & Hylemon, P. B. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1127483 · Cited by 1,100
Clostridium difficile colitis: pathogenesis and host defence
Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.108 · Cited by 551
Theriot, C. M., Bowman, A. A., & Young, V. B. (2016) · mSphere · doi:10.1128/msphere.00045-15 · Cited by 481
“Previous in vitro studies looking at the interaction between bile acids and C. difficile spore germination and growth observed inhibition of germination with MCA, LCA, and UDCA and inhibition of growth with MCA, LCA, and DCA (12, 22, 25, 26, 28, 32, 33).”
BackgroundMethodThanissery, R., Winston, J. A., & Theriot, C. M. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.03.004 · Cited by 242
“difficile UK1, M68, and VPI 10463, and growth of strains CD196, UK14, UK1, M68, and VPI 10463 in vitro [11, 28, 29].”
BackgroundStuder, N., Desharnais, L., Beutler, M., Brugiroux, S., Terrazos, M. A., Menin, L., Schürch, C. M., McCoy, K. D., Kuehne, S. A., Minton, N. P., et al. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00191 · Cited by 195
“Like many other intestinal commensal species, 7- dehydroxylating bacteria are understudied in vivo.”
Background
Metadata
- Authors
- Francis, M. B., Allen, C. A., & Sorg, J. A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-09
- Volume
- 8
- Issue
- 9
- Pages
- e73653
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1974402925
- Cited by
- 67
- References
- 12
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.